ArticleCardiovascular and interventional radiology2026
Minimally Invasive Treatment of Aneurysmal Bone Cysts Utilizing a Modified Sclerograft Technique.
Article in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAneurysmal bone cysts (ABCs) are locally aggressive expansile bone tumors that typically present near the metaphysis and are commonly encountered in the pediatric population. This study presents the results of a single staged procedure, which is a modification of the Sclerograft procedure (chemical sclerotherapy combined with regenerative bone grafting) used to treat unicameral bone cysts (UBCs), as an alternative treatment paradigm. MATERIALS AND
methodsThis retrospective, single-institution study included patients with MRI-confirmed primary aneurysmal bone cysts of the appendicular skeleton treated between 2020 and 2025. Eligible patients underwent mechanical disruption with doxycycline sclerotherapy (± cryoablation) and regenerative bone grafting. Demographics, lesion characteristics, prior treatments, imaging, and clinical outcomes were analyzed.
resultsThe final cohort included 27 patients (15 females, 12 males) with a mean age of 10.6 years. The primary outcome was the reintervention rate. Patients underwent a median of 1 procedure (range 1-3; mean 1.33) over a median follow-up of 1.88 years (range 0.5-5.8 years). 7 of 27 (25.9%) required at least one additional procedure due to radiographic (Modified Neer Grade 3-4) and symptomatic recurrence. Median time to retreatment was 12.2 months (IQR 6.8-19.4). Radiographs were the primary follow-up imaging modality (92.6%).
conclusionThe modified Sclerograft technique is a feasible, single-session treatment option for primary aneurysmal bone cysts with promising results that warrant further study as a possible alternative to the historical paradigm of serial sclerotherapy. Utilizing regenerative bone graft facilitates bone formation and permits the majority of follow-up to be performed with plain radiographs.
Indexed as
Identifiers
42477120What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.